Sotera Health Company
SHCHealthcareNASDAQDiagnostics & Research
Scan Results
Daily timeframePart of the healthcare sector, Sotera Health Company (SHC) is listed under Diagnostics & Research. With a market capitalization of $5.18B, it sits in mid-cap territory. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.
Market Cap
$5.18B
Beta
1.77
P/E (TTM)
43.21
P/E (Fwd)
17.12
EPS (TTM)
$0.42
EPS (Fwd)
$1.06
ROE
22.7%
ROA
8.5%
Cash
$314.4M
Total Debt
$2.27B
Free CF
$144.8M
52W Change
61.6%
Annual Financials
Cash vs Debt
The company holds $314.4M in cash, though total debt stands at $2.27B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $144.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 22.7% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $1.00B to $1.16B.
Sotera Health Company's elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. Sotera Health Company carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Sotera Health Company and its sector.